Register now
WEBINAR
GIANT's Healthy Innovators Live TV with Barry Shrier: Season 4 Episode 1
November 4, 2021

Host of "Healthy Innovators" TV Show and Founder of the GIANT Health Event, Barry Shrier, discusses the latest in health innovations with his guest panel:

- Ralf Jahns, Co-Founder & Managing Director, Research2Guidance

- Adam Samson, Senior Director of Clinical Operations & Customer Success, Curebase

- Isabel Cassidy-Soto, Digital Health Consultant, Research2Guidance

Decentralized clinical trials (DCTs) are an alternative to traditional clinical trial methods and involve using digital tools to enable remote data collection. These change the research paradigm by removing the site as the “center” of the trial, allow both patients and investigators to participate from their homes. These processes are facilitated with tools such as electronic data capture (EDC) platforms, integration of health wearables and sensors, telemedicine, and trained clinical trial staff. Companies offering services for decentralized trials claim numerous efficiency and cost-saving benefits. The sector has experienced significant hype and growth since the beginning of the COVID-19 pandemic as we see increased revenue, investment, and M&A activity.

About Curebase
Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.  

This starts with Curebase’s leading decentralized clinical trial software platform that is an all-in-one, purpose built eClinical software system, with every tool needed to manage and collect data for decentralized clinical trials. This includes ePRO, eCOA, eConsent, Telemedicine, and much more. Curebase also offers a virtual research site, complete with virtual investigators, research coordinators, mobile nursing, and other healthcare staff that administer care to patients where convenient for them, just like any other research site, but with the ability to stand up anywhere and with greater patient convenience and reach. Notably, Curebase is the pioneer of the “BYOP” or Bring Your Own Physician model, allowing patients to use their own doctors to participate in clinical trials. 

We are reinventing a $45B market, enabling drug and device companies to increase the volume, quality, and speed of data collection regardless of patients’ physical location. COVID-19 tailwinds have created massive demand for telemedicine and home-based trials, with two new FDA guidance letters and industry-wide adoption of remote remote research that will only accelerate in the years to come. You can learn more about Curebase and our next stage of growth in Crunchbase, Fierce Biotech, and MedCity News!

You can learn more in a 1-1 meeting with Curebase.
Request a Meeting
Or, subscribe to our blog and other educational updates.
Reserve your spot today!

Curebase Webinar

GIANT's Healthy Innovators Live TV with Barry Shrier: Season 4 Episode 1

November 4, 2021
Featured speaker:
Adam Samson
Senior Director, Clinical Operations and Customer Success
Adam Samson
Senior Director, Clinical Operations and Customer Success
Nov 4, 2021 1:00 PM
EST
free
About the Webinar
Collaborate with patient representatives for software configuration and user testing
Assist patients along their treatment journey with patient-centric software and communication tools
Closely monitor data in real-time to gain actionable insights into the patient experience

Host of "Healthy Innovators" TV Show and Founder of the GIANT Health Event, Barry Shrier, discusses the latest in health innovations with his guest panel:

- Ralf Jahns, Co-Founder & Managing Director, Research2Guidance

- Adam Samson, Senior Director of Clinical Operations & Customer Success, Curebase

- Isabel Cassidy-Soto, Digital Health Consultant, Research2Guidance

Decentralized clinical trials (DCTs) are an alternative to traditional clinical trial methods and involve using digital tools to enable remote data collection. These change the research paradigm by removing the site as the “center” of the trial, allow both patients and investigators to participate from their homes. These processes are facilitated with tools such as electronic data capture (EDC) platforms, integration of health wearables and sensors, telemedicine, and trained clinical trial staff. Companies offering services for decentralized trials claim numerous efficiency and cost-saving benefits. The sector has experienced significant hype and growth since the beginning of the COVID-19 pandemic as we see increased revenue, investment, and M&A activity.

About Curebase
Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.  

This starts with Curebase’s leading decentralized clinical trial software platform that is an all-in-one, purpose built eClinical software system, with every tool needed to manage and collect data for decentralized clinical trials. This includes ePRO, eCOA, eConsent, Telemedicine, and much more. Curebase also offers a virtual research site, complete with virtual investigators, research coordinators, mobile nursing, and other healthcare staff that administer care to patients where convenient for them, just like any other research site, but with the ability to stand up anywhere and with greater patient convenience and reach. Notably, Curebase is the pioneer of the “BYOP” or Bring Your Own Physician model, allowing patients to use their own doctors to participate in clinical trials. 

We are reinventing a $45B market, enabling drug and device companies to increase the volume, quality, and speed of data collection regardless of patients’ physical location. COVID-19 tailwinds have created massive demand for telemedicine and home-based trials, with two new FDA guidance letters and industry-wide adoption of remote remote research that will only accelerate in the years to come. You can learn more about Curebase and our next stage of growth in Crunchbase, Fierce Biotech, and MedCity News!

You can learn more in a 1-1 meeting with Curebase
Book a meeting
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States

Register for Webinar

We'd love to hear from you, whether a Sponsor interested in running a study with us, a provider looking to get involved in clinical research, or patients interested in our studies. Fill out your information below and one of our team members will be in touch.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.